WO2026132842 - PRE-FILLED SYRINGE OF AQUEOUS SOLUTION OF PARACETAMOL AND/OR IBUPROFEN SUITABLE FOR INJECTABLE ADMINISTRATION
National phase entry is expected:
Publication Number
WO/2026/132842
Publication Date
25.06.2026
International Application No.
PCT/GR2025/000023
International Filing Date
12.12.2025
Title **
[English]
PRE-FILLED SYRINGE OF AQUEOUS SOLUTION OF PARACETAMOL AND/OR IBUPROFEN SUITABLE FOR INJECTABLE ADMINISTRATION
[French]
SERINGUE PRÉREMPLIE DE SOLUTION AQUEUSE DE PARACÉTAMOL ET/OU D'IBUPROFÈNE ADAPTÉE À L'ADMINISTRATION INJECTABLE
Applicants **
TSETI, Ioulia
Inventors
TSETI, Ioulia
Priority Data
20240100898
18.12.2024
GR
20250101047
11.12.2025
GR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2116 | |
| EPO | Filing, Examination, Granting | 6663 | |
| Japan | Filing, Examination, Granting | 2264 | |
| South Korea | Filing, Examination, Granting | 2207 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
17,990
Contact Us
Abstract[English]
The present invention relates to a pre-filled syringe (PFS) comprising a pharmaceutical composition of an aqueous solution for use in injectable administration, wherein the composition comprises a) paracetamol and/or b) ibuprofen in the form of either sodium salt or lysine, and comprises co-solvents, wherein the co-solvents are ethanol and/or glycerin and/or one or more cyclodextrins.[French]
La présente invention concerne une seringue préremplie (PFS) comprenant une composition pharmaceutique d'une solution aqueuse destinée à être utilisée en administration injectable, ladite composition comprenant a) du paracétamol et/ou b) de l'ibuprofène sous forme de sel de sodium ou de lysine, et comprenant des cosolvants, les cosolvants étant de l'éthanol et/ou de la glycérine et/ou une ou plusieurs cyclodextrines.